Steward Partners Investment Advisory’s Array Biopharma Inc ARRY Stock Holding History

Steward Partners Investment Advisory’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-150	Closed	-$6K	–	2874
2019 Q2	$6K	Buy	+150	New	+$4.21K	﹤0.01%	2196
2018 Q4	–	Sell	-150	Closed	-$2K	–	2527
2018 Q3	$2K	Hold	150	–	–	﹤0.01%	2447
2018 Q2	$3K	Buy	+150	New	+$2.39K	﹤0.01%	2177

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Steward Partners Investment Advisory's ARRY Position: Q3 2019 in Review

Steward Partners Investment Advisory sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 150 shares — an estimated $6K sold.

Steward Partners Investment Advisory first reported a position in ARRY in Q2 2018 and held it in 3 quarters. The position peaked at $6K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Steward Partners Investment Advisory reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Steward Partners Investment Advisory sold 150 Array Biopharma Inc shares in Q3 2019, an estimated $6K.
Steward Partners Investment Advisory first reported a position in Array Biopharma Inc in Q2 2018 and held it in 3 quarters.
Steward Partners Investment Advisory's Array Biopharma Inc position peaked at $6K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2019, filed 30 Oct 2019.